Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”

Detalles Bibliográficos
Autor principal: Wambier, Carlos Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779256/
https://www.ncbi.nlm.nih.gov/pubmed/33408021
http://dx.doi.org/10.1016/j.ijantimicag.2020.106175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779256/
https://www.ncbi.nlm.nih.gov/pubmed/33408021
http://dx.doi.org/10.1016/j.ijantimicag.2020.106175

Ejemplares similares